Sinovac Biotech Ltd. Sets New 1-Year High at $6.22 (SVA)
Shares of Sinovac Biotech (NYSE:SVA) hit a new 52-week high during trading hours on Monday, StockRatingsNetwork reports. The company traded as high as $6.22 and last traded at $6.15, with a volume of 343,350 shares trading hands. The stock had previously closed at $6.08.
A number of research firms have recently commented on SVA. Analysts at TheStreet upgraded shares of Sinovac Biotech (NYSE:SVA) from a “sell” rating to a “hold” rating in a research note to investors on Friday, August 16th. Analysts at Aegis upgraded shares of Sinovac Biotech (NYSE:SVA) from a “hold” rating to a “buy” rating in a research note to investors on Thursday, August 15th. They now have a $7.00 price target on the stock, up previously from $4.00.
Sinovac Biotech has a one year low of $2.21 and a one year high of $6.22. The stock’s 50-day moving average is $4.85 and its 200-day moving average is $4.01. The company’s market cap is $339.7 million.
Sinovac Biotech Ltd. (NYSE:SVA) is a holding company that conducts its business in China through its 71.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.